The acid reflux medication lansoprazole is frequently prescribed by doctors and asthma specialist for kids and adults who suffer from asthma. Lansoprazole has become an increasingly popular option for the treatment of asthma in children over the last 10 years, but recent test groups prove Lansoprazole should not be taken by anyone with the purpose of treating bronchial asthma.
Recent findings from the American Lung Association’s Asthma Clinical Group suggest that these acid reflux drugs such as lansoprazole are not an effective treatment for asthma in children and may even lead to added asthma complications and health issues, namely infections of the upper respiratory system.
“The data were very clear. Lansoprazole did not improve asthma symptoms in children as compared to a placebo, and there is no evidence to support prescribing these drugs to treat asthma in children.”
Janet Holbrook, Composer of the study.
A branch of this study conducted beforehand by the same group on adult subjects came to the same conclusion: acid reflux medications (lansoprazole) are an ineffective, possibly harmful treatment for bronchial asthma. This research on acid reflux medication to treat asthma in children was featured in the January 25th issue of JAMA (The Journal of the American Medical Association).
NHLBI (The National Heart, Lung, and Blood Institute) financed this research on acid reflux medication and its possible application in the treatment of asthma symptoms.